This document is provided strictly for educational and informational purposes related to laboratory research. The compounds referenced within this material are research chemicals intended for laboratory research use only and are not approved for human or veterinary consumption. The information contained in this document does not constitute medical advice, treatment recommendations, or dosing guidance for humans or animals. Any protocols, dosing schedules, or procedures described are derived from published or investigational research models and are presented solely for the purpose of scientific reference and discussion. Many compounds referenced in this document are investigational substances that have not been approved by the U.S. Food and Drug Administration (FDA). By accessing this document, the reader acknowledges the information is for research and educational reference only.
CJC-1295 is a GHRH analogue that stimulates the pituitary to release GH in pulses. Ipamorelin is a GHRP (growth hormone releasing peptide) that also triggers GH release but through a different pathway. Together they create a powerful, synergistic GH pulse — often called the "stack" for fat loss, muscle gain, and recovery.
🧪 Reconstitution
Use 1ml (1cc) each of BAC water.
🌡️ Keep peptides refrigerated at 36–46°F (2–8°C) at all times.
CJC-1295 dose: 100mcg per injection
Ipamorelin dose: 200–300mcg per injection
Frequency: 2–3x daily (especially before bed and morning)
Method: Subcutaneous injection
Timing: Fasted (away from meals/insulin)
⚠️ Side Effects
Common / Not Concerning
Mild water retention
Injection site redness or irritation
Temporary fatigue or headache
Increased hunger
Monitor Closely
Carpal tunnel symptoms with prolonged high-dose use
Blood sugar — GH can affect insulin sensitivity
For research and educational purposes only. Not medical advice. Always consult a licensed healthcare professional.